About Surgical Incision Management
Poor incision healing can lead to serious patient consequences such as surgical site infections (SSI), dehiscence, hematoma or seromas.
KCI provides advanced negative pressure therapies and post-operative dressings designed to help manage and protect closed surgical incisions.
Products described on this website (and associated product information), may not be available for sale in all markets as a result of local regulatory requirements. For information regarding product availability in your market, please contact your local Acelity/KCI representative here.
The Science Behind Our Products
KCI solutions are built on an extensive understanding of incision management, supported by a large body of clinical evidence
Timely incision management can help reduce the human and economic costs of SSIs. Complications with incision healing lead to serious patient consequences.
- There are 8.2 million people at risk for Surgical Site Infections (SSI)1
- SSIs account for 21.8% of all healthcare-associated infections2
- Of the top 5 Healthcare Acquired Infections (HAIs), SSIs account for 33.7% of the $9.8 billion cost to the healthcare system*1
*Top five HAIs are central line-associated bloodstream infections (CLABSI), ventilator-associated pneumonia (VAP), Clostridium difficile infection (C diff), surgical site infection and catheter-associated urinary tract infection (CAUTI).
The PREVENA™ Incision Management System is the first powered negative pressure device specifically designed for the management of closed surgical incisions. Specific indications, contraindications, warnings, precautions and safety information exist for PREVENA™ Therapy. Please consult the applicable PREVENA™ System Clinician Guide instructions for use prior to application.
For less compromised patients TIELLE™ Lite Dressing may be used in low to non-exuding and bleeding wounds, such as surgical and traumatic wounds3. ADAPTIC TOUCH™ Non-Adhering Silicone Dressing is designed as a primary wound contact layer for use in the management of dry to heavily exuding, partial and full-thickness chronic wounds including venous ulcers, decubitus (pressure) ulcers and diabetic ulcers, and for traumatic and surgical wounds, donor sites and 1st and 2nd degree burns. It is also suitable for use, under medical supervision, with negative pressure wound therapy (NPWT) for the protection of fragile wound structures.
KCI offers a wide range of clinically proven, economically beneficial incision management technologies for closed surgical incisions. These can contribute to positive outcomes for patients and healthcare professionals.